Clinical Trials Directory

Trials / Unknown

UnknownNCT05961293

NeuroGlove fMRI Study

Impact of Peripheral Sensory Stimulation of the Hand in the Treatment of Stroke: A Preliminary Functional MRI Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
13 (estimated)
Sponsor
NeuroGlove LLC · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This is a prospective, single center, interventional clinical study containing two cohorts the treatment cohort and control cohort. A total of 13 subjects will be enrolled. Three (3) healthy volunteers will be enrolled in the control cohort and undergo imaging only. Ten (10) subjects who have recently experienced a mild to moderate acute ischemic stroke will receive treatment using the NeuroGlove.

Detailed description

This is a prospective, single center, interventional clinical study containing two cohorts the treatment cohort and control cohort. A total of 13 subjects will be enrolled. Three (3) healthy volunteers will be enrolled in the control cohort and undergo imaging only. Ten (10) subjects who have recently experienced a mild to moderate acute ischemic stroke will receive treatment using the NeuroGlove. Up to 13 subjects enrolled and complete study procedures. There will be 2 cohorts enrolled in the study: 1. Control Cohort: 3 healthy volunteers 2. Treatment Cohort: 10 subjects who have experienced mild to moderate stroke symptoms\* that did not completely resolve after acute interventions. * Mild to moderate stroke symptoms is defined as a NIHSSS score of 3 to 15.

Conditions

Interventions

TypeNameDescription
DEVICENeuroGloveNeuroGlove is a non-invasive device that provides peripheral somatosensory stimulation to the hand of a stroke victim during acute, subacute, or chronic phases of a stroke. NeuroGlove provides sensory stimulation in the forms of pneumatic puffs of air. There is some early evidence that early peripheral sensory stimulation may improve neurological outcomes following an ischemic stroke.

Timeline

Start date
2024-12-01
Primary completion
2024-12-01
Completion
2024-12-15
First posted
2023-07-27
Last updated
2024-08-27

Source: ClinicalTrials.gov record NCT05961293. Inclusion in this directory is not an endorsement.